Lunit Appoints Craig Hadfield as CEO of Volpara, Strengthening AI-Powered Cancer Detection Leadership
27th February, 2025
Hadfield succeeds Dr. Ralph Highnam, who transitions to Chief Science & Innovation Officer, as Volpara accelerates global growth in AI-driven cancer detection and prevention.
Craig Hadfield, newly appointed CEO of Volpara (Courtesy of Lunit)
Lunit (KRX: 328130) has announced the appointment of Craig Hadfield as the new CEO of Volpara Health, effective April 1, 2025. Hadfield, currently CFO of Volpara, succeeds Dr. Ralph Highnam, who will transition to Chief Science & Innovation Officer and continue as an Executive Director on the Board.
With over 25 years of financial and operational experience, Hadfield has been instrumental in Volpara’s global expansion and strategic growth. His leadership aims to strengthen Volpara’s position in AI-powered cancer detection and prevention.
“Craig’s expertise and deep understanding of Volpara’s mission make him the ideal leader for our next growth phase,” said Brandon Suh, CEO of Lunit.
The transition aligns with Lunit’s commitment to advancing AI-driven healthcare solutions, reinforcing Volpara’s global impact in early cancer detection and imaging innovation.
Medtech Special
- Spinal Resources Inc. Secures Patent for Bezier Parametric Curve Spinal Rod System
- Lunit AI Boosts Cancer Detection in Largest Single-Reading Mammography Study
- Baird Medical Gains Indonesian Regulatory Approval for Microwave Ablation Technology
- Medtronic’s SMART Trial Confirms Evolut™ TAVR’s Superior Valve Performance at Two Years
- Zimmer Biomet Wins FDA Nod for Metal-Safe Knee Implant
- SkinCure Oncology Submits GentleBeam™ for FDA Clearance, Expanding Noninvasive Skin Cancer Treatment
- Stryker’s Inari Medical Introduces Artix Thrombectomy System to Enhance Arterial Clot Removal
Artificial Intelligence Breakthroughs
- MoveUP Acquires Deep Structure AI to Elevate AI-Powered Orthopedic Care
- CLEW Launches AI-Powered Sepsis Virtual Unit to Strengthen SEP-1 Compliance
- Lunit AI Boosts Cancer Detection in Largest Single-Reading Mammography Study
- Zimmer Biomet Wins FDA Nod for Metal-Safe Knee Implant
- OSE Immunotherapeutics and Scienta Lab partner to advance AI-driven Precision Immunotherapy
- Optellum and Volpara Health Partner to Enhance AI-Driven Cancer Risk Assessment
- Synergy Laboratories Introduces AI-Powered Genius™ Digital Diagnostics System for Advanced Cervical Cancer Screening
Robots In Medtech
- Australia's University of Queensland Unveils shape-shifting Liquid Metal Robotics
- India's SS Innovations makes history with first robotic cardiac surgery in Indonesia
- Momentis Surgical Secures FDA Clearance for Advanced Anovo® Robotic Platform, Setting New Standards in Single-Incision Surgery
- Momentis Surgical expands to general surgery market with FDA 510(k) clearance for its Anovo Robotic system
- Intuitive and India-based KIMS Hospitals sign MoU to launch 25 new robotic surgery programmes
- ZEISS introduces its latest Robotic Visualisation System for neuro surgery
- Surgical robotics pioneer Intuitive opens Global Capability Centre in Bengaluru, India
Asia Pacific
Global / International
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer